{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:15:34Z","timestamp":1789600534648,"version":"build-2803163510"},"reference-count":27,"publisher":"American Society of Hematology","issue":"10","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,5,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Inadequate diagnostics compromise cancer care across lower- and middle-income countries (LMICs). We hypothesized that an inexpensive gene expression assay using paraffin-embedded biopsy specimens from LMICs could distinguish lymphoma subtypes without pathologist input. We reviewed all biopsy specimens obtained at the Instituto de Cancerolog\u00eda y Hospital Dr. Bernardo Del Valle in Guatemala City between 2006 and 2018 for suspicion of lymphoma. Diagnoses were established based on the World Health Organization classification and then binned into 9 categories: nonmalignant, aggressive B-cell, diffuse large B-cell, follicular, Hodgkin, mantle cell, marginal zone, natural killer\/T-cell, or mature T-cell lymphoma. We established a chemical ligation probe-based assay (CLPA) that quantifies expression of 37 genes by capillary electrophoresis with reagent\/consumable cost of approximately $10\/sample. To assign bins based on gene expression, 13 models were evaluated as candidate base learners, and class probabilities from each model were then used as predictors in an extreme gradient boosting super learner. Cases with call probabilities &amp;lt; 60% were classified as indeterminate. Four (2%) of 194 biopsy specimens in storage &amp;lt;3 years experienced assay failure. Diagnostic samples were divided into 70% (n = 397) training and 30% (n = 163) validation cohorts. Overall accuracy for the validation cohort was 86% (95% confidence interval [CI]: 80%-91%). After excluding 28 (17%) indeterminate calls, accuracy increased to 94% (95% CI: 89%-97%). Concordance was 97% for a set of high-probability calls (n = 37) assayed by CLPA in both the United States and Guatemala. Accuracy for a cohort of relapsed\/refractory biopsy specimens (n = 39) was 79% and 88%, respectively, after excluding indeterminate cases. Machine-learning analysis of gene expression accurately classifies paraffin-embedded lymphoma biopsy specimens and could transform diagnosis in LMICs.<\/jats:p>","DOI":"10.1182\/bloodadvances.2021004347","type":"journal-article","created":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T15:36:54Z","timestamp":1621006614000},"page":"2447-2455","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":22,"title":["Low-cost transcriptional diagnostic to accurately categorize lymphomas in low- and middle-income countries"],"prefix":"10.1182","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0687-2419","authenticated-orcid":false,"given":"Fabiola","family":"Valvert","sequence":"first","affiliation":[{"name":"La Liga Nacional Contra el C\u00e1ncer de Guatemala y El Instituto de Cancerolog\u00eda y Hospital Dr. Bernardo del Valle, Guatemala, Guatemala;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0808-2592","authenticated-orcid":false,"given":"Oscar","family":"Silva","sequence":"additional","affiliation":[{"name":"Department of Pathology, Stanford University School of Medicine, Stanford, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Sol\u00f3rzano-Ortiz","sequence":"additional","affiliation":[{"name":"La Liga Nacional Contra el C\u00e1ncer de Guatemala y El Instituto de Cancerolog\u00eda y Hospital Dr. Bernardo del Valle, Guatemala, Guatemala;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maneka","family":"Puligandla","sequence":"additional","affiliation":[{"name":"Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos Mauricio","family":"Sili\u00e9zar Tala","sequence":"additional","affiliation":[{"name":"La Liga Nacional Contra el C\u00e1ncer de Guatemala y El Instituto de Cancerolog\u00eda y Hospital Dr. Bernardo del Valle, Guatemala, Guatemala;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Guyon","sequence":"additional","affiliation":[{"name":"DxTerity Diagnostics, Rancho Dominguez, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel L.","family":"Dixon","sequence":"additional","affiliation":[{"name":"DxTerity Diagnostics, Rancho Dominguez, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelly","family":"L\u00f3pez","sequence":"additional","affiliation":[{"name":"La Liga Nacional Contra el C\u00e1ncer de Guatemala y El Instituto de Cancerolog\u00eda y Hospital Dr. Bernardo del Valle, Guatemala, Guatemala;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4038-4777","authenticated-orcid":false,"given":"Francisco","family":"L\u00f3pez","sequence":"additional","affiliation":[{"name":"La Liga Nacional Contra el C\u00e1ncer de Guatemala y El Instituto de Cancerolog\u00eda y Hospital Dr. Bernardo del Valle, Guatemala, Guatemala;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1515-0656","authenticated-orcid":false,"given":"C\u00e9sar Camilo","family":"Car\u00edas Alvarado","sequence":"additional","affiliation":[{"name":"La Liga Nacional Contra el C\u00e1ncer de Guatemala y El Instituto de Cancerolog\u00eda y Hospital Dr. Bernardo del Valle, Guatemala, Guatemala;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Terbrueggen","sequence":"additional","affiliation":[{"name":"DxTerity Diagnostics, Rancho Dominguez, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen E.","family":"Stevenson","sequence":"additional","affiliation":[{"name":"Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasodha","family":"Natkunam","sequence":"additional","affiliation":[{"name":"Department of Pathology, Stanford University School of Medicine, Stanford, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8724-3907","authenticated-orcid":false,"given":"David M.","family":"Weinstock","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Harvard Medical School, Boston, MA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0330-2752","authenticated-orcid":false,"given":"Edward L.","family":"Briercheck","sequence":"additional","affiliation":[{"name":"University of Washington\/Fred Hutchinson Cancer Research Center, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2021,5,14]]},"reference":[{"issue":"1","key":"2021061015012002200_B1","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1200\/JCO.2015.61.9189","article-title":"structural barriers to diagnosis and treatment of cancer in low- and middle-income countries: the urgent need for scaling up","volume":"34","author":"Cazap","year":"2016","journal-title":"J Clin Oncol"},{"key":"2021061015012002200_B2","article-title":"Second WHO model list of essential in vitro diagnostics.","author":"World Health Organization"},{"key":"2021061015012002200_B3","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1200\/EDBK_175251","article-title":"Cancer care and control as a human right: recognizing global oncology as an academic field","volume":"37","author":"Eniu","year":"2017","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"9747","key":"2021061015012002200_B4","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/S0140-6736(10)61152-X","article-title":"Expansion of cancer care and control in countries of low and middle income: a call to action","volume":"376","author":"Farmer","year":"2010","journal-title":"Lancet"},{"issue":"20","key":"2021061015012002200_B5","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"2021061015012002200_B6","doi-asserted-by":"crossref","first-page":"S255","DOI":"10.1097\/QAD.0000000000002386","article-title":"National HIV testing and diagnosis coverage in sub-Saharan Africa: a new modeling tool for estimating the \u201cfirst 90\u201d from program and survey data","volume":"33","author":"Maheu-Giroux","year":"2019","journal-title":"AIDS"},{"issue":"1","key":"2021061015012002200_B7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jmoldx.2014.08.006","article-title":"Molecular classification of MYC-driven B-cell lymphomas by targeted gene expression profiling of fixed biopsy specimens","volume":"17","author":"Carey","year":"2015","journal-title":"J Mol Diagn"},{"issue":"3","key":"2021061015012002200_B8","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nbt1385","article-title":"Direct multiplexed measurement of gene expression with color-coded probe pairs [published correction appears in Nat Biotechnol. 2008;26:709]","volume":"26","author":"Geiss","year":"2008","journal-title":"Nat Biotechnol"},{"issue":"6","key":"2021061015012002200_B9","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.jmoldx.2017.07.007","article-title":"Determination of molecular subtypes of diffuse large B-cell lymphoma using a reverse transcriptase multiplex ligation-dependent probe amplification classifier: a CALYM study","volume":"19","author":"Bob\u00e9e","year":"2017","journal-title":"J Mol Diagn"},{"issue":"3","key":"2021061015012002200_B10","doi-asserted-by":"crossref","first-page":"S1525","DOI":"10.1016\/j.jmoldx.2015.01.007","article-title":"Accurate classification of germinal center B-cell-like\/activated B-cell-like diffuse large B-cell lymphoma using a simple and rapid reverse transcriptase-multiplex ligation-dependent probe amplification assay: a CALYM study","volume":"17","author":"Mareschal","year":"2015","journal-title":"J Mol Diagn"},{"issue":"22","key":"2021061015012002200_B11","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1182\/blood-2018-05-851154","article-title":"Molecular classification of primary mediastinal large B-cell lymphoma using routinely available tissue specimens","volume":"132","author":"Mottok","year":"2018","journal-title":"Blood"},{"issue":"23","key":"2021061015012002200_B12","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMoa055759","article-title":"Molecular diagnosis of Burkitt\u2019s lymphoma","volume":"354","author":"Dave","year":"2006","journal-title":"N Engl J Med"},{"issue":"database issue","key":"2021061015012002200_B13","first-page":"D871","article-title":"The Stanford Tissue Microarray Database","volume":"36","author":"Marinelli","year":"2008","journal-title":"Nucleic Acids Res"},{"issue":"17","key":"2021061015012002200_B14","doi-asserted-by":"crossref","first-page":"9991","DOI":"10.1073\/pnas.1732008100","article-title":"A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma","volume":"100","author":"Wright","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"2021061015012002200_B15","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jmoldx.2014.11.002","article-title":"A novel technology for multiplex gene expression analysis directly from whole blood samples stabilized at ambient temperature using an RNA-stabilizing buffer","volume":"17","author":"Kim","year":"2015","journal-title":"J Mol Diagn"},{"issue":"10133","key":"2021061015012002200_B16","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/S0140-6736(18)30458-6","article-title":"Access to pathology and laboratory medicine services: a crucial gap","volume":"391","author":"Wilson","year":"2018","journal-title":"Lancet"},{"issue":"18","key":"2021061015012002200_B17","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1200\/JCO.2016.71.2083","article-title":"Impact of expert pathologic review of lymphoma diagnosis: study of patients from the French Lymphopath Network","volume":"35","author":"Laurent","year":"2017","journal-title":"J Clin Oncol"},{"issue":"6","key":"2021061015012002200_B18","doi-asserted-by":"crossref","first-page":"947","DOI":"10.5858\/2007-131-947-QAOTBT","article-title":"Quantitative assessment of the BCR-ABL transcript using the Cepheid Xpert BCR-ABL Monitor assay","volume":"131","author":"Dufresne","year":"2007","journal-title":"Arch Pathol Lab Med"},{"issue":"19","key":"2021061015012002200_B19","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1182\/blood-2013-11-536359","article-title":"Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma","volume":"123","author":"Iqbal","year":"2014","journal-title":"Blood"},{"issue":"1","key":"2021061015012002200_B20","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1471-2407-14-153","article-title":"Ki-67 is a valuable prognostic predictor of lymphoma but its utility varies in lymphoma subtypes: evidence from a systematic meta-analysis","volume":"14","author":"He","year":"2014","journal-title":"BMC Cancer"},{"issue":"5","key":"2021061015012002200_B21","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.3109\/10428194.2013.827787","article-title":"Evaluation of a panel of expert pathologists: review of the diagnosis and histological classification of Hodgkin and non-Hodgkin lymphomas in a population-based cancer registry","volume":"55","author":"Strobbe","year":"2014","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"2021061015012002200_B22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4274\/tjh.2016.0344","article-title":"Discrepancies in lymphoma diagnosis over the years: a 13-year experience in a tertiary center","volume":"34","author":"\u00d6zkaya","year":"2017","journal-title":"Turk J Haematol"},{"issue":"6","key":"2021061015012002200_B23","doi-asserted-by":"crossref","first-page":"650","DOI":"10.6004\/jnccn.2019.0029","article-title":"NCCN guidelines insights: B-cell lymphomas, version 3.2019","volume":"17","author":"Zelenetz","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"issue":"2","key":"2021061015012002200_B24","doi-asserted-by":"crossref","first-page":"123","DOI":"10.6004\/jnccn.2018.0007","article-title":"NCCN guidelines insights: T-cell lymphomas, version 2.2018","volume":"16","author":"Horwitz","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"issue":"12","key":"2021061015012002200_B25","doi-asserted-by":"crossref","first-page":"e609","DOI":"10.1016\/S2352-3026(18)30177-7","article-title":"Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study","volume":"5","author":"Dunleavy","year":"2018","journal-title":"Lancet Haematol"},{"issue":"21","key":"2021061015012002200_B26","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1200\/JCO.18.01994","article-title":"Dose-adjusted EPOCH-R compared with R-CHOP as frontline therapy for diffuse large B-cell lymphoma: clinical outcomes of the phase III intergroup trial alliance\/CALGB 50303","volume":"37","author":"Bartlett","year":"2019","journal-title":"J Clin Oncol"},{"issue":"5","key":"2021061015012002200_B27","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","article-title":"Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes [published corrections appear in Nat Med. 2018;24:1292 and Nat Med. 2018;24:1290-1291]","volume":"24","author":"Chapuy","year":"2018","journal-title":"Nat Med"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/5\/10\/2447\/1809330\/advancesadv2021004347.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/5\/10\/2447\/1809330\/advancesadv2021004347.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T15:29:06Z","timestamp":1623338946000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/5\/10\/2447\/475907\/Low-cost-transcriptional-diagnostic-to-accurately"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,14]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,5,25]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2021004347","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,14]]}}}